ZAQS.ORG

Healthy Returns: Botox, Trulicity among 15 drugs added to Medicare price negotiations

7 hours ago

Danaher stock fails to rise on solid earnings — leading us to question what's next

9 hours ago

UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround

9 hours ago

Next up in weight loss drugs: More pills, easier access and drug combinations

1 day ago

Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s

5 days ago

Amazon launches AI health-care tool for One Medical members

7 days ago

OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion

7 days ago

Another alliance of health care and AI signals why pharma stocks could be back

7 days ago

Drug pricing, patent losses, deals: What pharma execs see ahead in the industry

8 days ago

Novo Nordisk shares rise after Wegovy obesity pill has 'solid' start to launch

8 days ago

Keeping U.S. biotech ahead of China's could help rare disease patients, experts say

12 days ago

Healthy Returns: Novo CEO on GLP-1 pricing, and more insights from the JPM conference

12 days ago

OpenAI acquires health-care technology startup Torch for $60 million: Source

14 days ago

Thanks for your support, here's how to connect with us

16 days ago

2026 is the year of obesity pills. Here's how they could reshape the GLP-1 market

18 days ago

Healthy Returns: What to expect from pharma at the JPM conference

19 days ago

Europe's best-performing blue-chip stock has become a prime takeover target

19 days ago

Patient advocates urge U.S. court to halt overseas prescription drug operations

19 days ago

CNBC launches CNBC Cures to help 30 million Americans with rare diseases

20 days ago

CNBC's Becky Quick details daughter's rare disease journey

20 days ago

OpenAI launches ChatGPT Health to connect user medical records, wellness apps

21 days ago

RFK Jr. unveils new nutrition guidelines, pushing more protein, less processed food

21 days ago

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

23 days ago

2026 will bring GLP-1 weight loss pills: These stocks will benefit from new habits

23 days ago

Lilly investors shouldn't sweat rival Novo having the first obesity pill on sale

27 days ago

Wegovy-maker Novo Nordisk shares surge after GLP-1 weight loss pill approval

1 month ago

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

1 month ago

The donors, insiders and data behind Trump's marijuana executive order

1 month ago

UnitedHealth Group commits to improvements after independent audit results

1 month ago

Wall Street banked on a flurry of deals in 2025. It wasn't that simple

1 month ago

Trump signs executive order reclassifying weed, opening door to broader access

1 month ago

Eli Lilly says obesity pill helps maintain weight loss after Wegovy, Zepbound

1 month ago

Medical supply firm Medline jumps more than 40% in debut after biggest IPO of 2025

1 month ago

Healthy Returns: 2026 will be the year of obesity pills

1 month ago